Intracellular Delivery of Biological Effectors
Details for Australian Patent Application No. 2008201592 (hide)
International Classifications
Event Publications
24 April 2008 Complete Application Filed
1 May 2008 Application Open to Public Inspection
Published as AU-B-2008201592
4 March 2010 Application Accepted
Published as AU-B-2008201592
22 April 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 30 Mar 2010. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 26 239 George Street Brisbane QLD 4000
12 August 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 30 Mar 2010
27 January 2011 Standard Patent Sealed
12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008201593-N, N'-substituted-1,3-diamino-2-hydroxypr opane derivatives
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser